Literature DB >> 16021437

Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions.

Said Benahmed1, Marie Christine Picot, Dominique Hillaire-Buys, Jean Pierre Blayac, Pierre Dujols, Pascal Demoly.   

Abstract

BACKGROUND: A firm diagnosis of drug hypersensitivity, because it may re-induce the reaction, is seldom confirmed. Causality assessment algorithms are therefore of interest. AIMS: The objective of this work was to compare three algorithms in the diagnosis of drug hypersensitivity.
METHODS: Evaluation of 120 clinical histories of drug hypersensitivity was carried out: 60 involving beta-lactams (50%) and 60 involving non-steroidal anti-inflammatory drugs (50%). Each of these groups of patients underwent a standardised allergy diagnosis, which included a detailed anamnesis, skin tests and, often, provocation tests under strict hospital surveillance. Unaware of the final allergy diagnosis, scores were established for all of the cases and compared using algorithms suggested by Begaud and coworkers [2, 20], Jones [13] and Naranjo et al. [21].
RESULTS: Although the methods of Jones [13] and Naranjo et al. [21] were perfectly concordant (k=1), no concordance was noted using the Begaud and coworkers [2, 20] method.
CONCLUSIONS: All three algorithms are dissimilar regarding the diagnosis of drug hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16021437     DOI: 10.1007/s00228-005-0962-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  General considerations for skin test procedures in the diagnosis of drug hypersensitivity.

Authors:  K Brockow; A Romano; M Blanca; J Ring; W Pichler; P Demoly
Journal:  Allergy       Date:  2002-01       Impact factor: 13.146

2.  Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations.

Authors:  W Aberer; A Bircher; A Romano; M Blanca; P Campi; J Fernandez; K Brockow; W J Pichler; P Demoly
Journal:  Allergy       Date:  2003-09       Impact factor: 13.146

3.  Adverse drug reaction monitoring: doing it the French way.

Authors:  N Moore; M Biour; G Paux; E Loupi; B Begaud; F Boismare; R J Royer
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

Review 4.  A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force.

Authors:  S G Johansson; J O Hourihane; J Bousquet; C Bruijnzeel-Koomen; S Dreborg; T Haahtela; M L Kowalski; N Mygind; J Ring; P van Cauwenberge; M van Hage-Hamsten; B Wüthrich
Journal:  Allergy       Date:  2001-09       Impact factor: 13.146

5.  Anaphylaxis. A review of 266 cases.

Authors:  S F Kemp; R F Lockey; B L Wolf; P Lieberman
Journal:  Arch Intern Med       Date:  1995-09-11

6.  [Mehtod for determination of undesirable effects of drugs].

Authors:  J Dangoumau; J C Evreux; J Jouglard
Journal:  Therapie       Date:  1978 May-Jun       Impact factor: 2.070

Review 7.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

Authors:  P Impicciatore; I Choonara; A Clarkson; D Provasi; C Pandolfini; M Bonati
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

Review 8.  Epidemiology of drug allergy.

Authors:  P Demoly; J Bousquet
Journal:  Curr Opin Allergy Clin Immunol       Date:  2001-08

9.  Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction.

Authors:  Djamel Messaad; Hocine Sahla; Said Benahmed; Philippe Godard; Jean Bousquet; Pascal Demoly
Journal:  Ann Intern Med       Date:  2004-06-15       Impact factor: 25.391

10.  Systems analysis of adverse drug events. ADE Prevention Study Group.

Authors:  L L Leape; D W Bates; D J Cullen; J Cooper; H J Demonaco; T Gallivan; R Hallisey; J Ives; N Laird; G Laffel
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

View more
  4 in total

1.  Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.

Authors:  Hélène Théophile; Yannick Arimone; Ghada Miremont-Salamé; Nicholas Moore; Annie Fourrier-Réglat; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.

Authors:  Sandra L Kane-Gill; Elizabeth A Forsberg; Margaret M Verrico; Steven M Handler
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

3.  Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority.

Authors:  Inês Ribeiro-Vaz; Joana Marques; Pascal Demoly; Jorge Polónia; Eva Rebelo Gomes
Journal:  Eur J Clin Pharmacol       Date:  2012-08-23       Impact factor: 2.953

4.  Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.

Authors:  Laura Dickinson; Masautso Chaponda; Daniel F Carr; Joep J van Oosterhout; Johnstone Kumwenda; David G Lalloo; Munir Pirmohamed; Robert S Heyderman; Saye H Khoo
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.